February 18, 2016

Intellectual Property and FDA Considerations for Biotechnology and Medical Device Projects


Effective product development in the medical device and biotechnology industries requires a company to understand both the intellectual property (IP) and Food and Drug Administration (FDA) implications of its work. By proposing a series of questions that participants can use to assess their projects, this seminar will help engineers, designers and project managers to better understand the medical device and biotechnology product development process. Companies integrating knowledge of FDA regulatory requirements and IP portfolio management into their product development processes are more likely to experience success.  

  • Understanding the basics of patent and FDA regulatory application processes
  • Identifying key intersection points between patent application and FDA regulatory processes
  • Implementing practical workforce tools for successful product development

Hamline University – Minneapolis
1600 Utica Avenue South
7th Floor
Saint Louis Park, MN 55416

Services and Industries


7:30 a.m. to 8:30 a.m. (registration)
8:00 a.m. to 9:30 a.m. (program)

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.